Latest Utilities News

ikeGPS delivered a robust 4Q25 with a 48% jump in annual subscription revenue exit run rate and secured major U.S. utility contracts, while declining a $170 million acquisition offer due to shareholder resistance.

Race Oncology has opened a second Australian clinical site for its Phase 1 trial of RC220 combined with doxorubicin in advanced solid tumours, aiming to speed patient enrolment and gather critical safety and efficacy data.

ikeGPS delivered a robust 4Q FY25 with a 48% jump in annual subscription revenue and closed NZ$12 million in contracts, while receiving a non-binding acquisition approach valuing the company at around NZ$165-170 million.

ikeGPS Group Limited reported a robust 48% increase in annual subscription revenue exit run rate for FY25, driven by major U.S. utility contracts, while declining a non-binding $170 million acquisition offer due to shareholder resistance.

Atturra Limited reports a robust first half of FY25 with revenue growth nearing 28%, driven by recent acquisitions and expanding service offerings, while updating full-year guidance amid cautious government sector risks.

Antilles Gold Limited is raising $1 million through a share and option placement to support working capital and development of its Nueva Sabana copper-gold mine in Cuba.

HMC Capital Limited has reported a remarkable 680% increase in profit for the half-year ended 31 December 2024, driven by key acquisitions and expansion into digital infrastructure and private credit sectors. The company also announced a fully franked interim dividend, underscoring confidence in its growth trajectory.

SRG Global has reported a record first half for FY25, posting a 21% revenue increase and upgrading its full-year profit guidance, driven by strong cash flow and successful integration of the Diona acquisition.

SRG Global has delivered a record first half in FY25, posting strong revenue and profit growth alongside a successful acquisition integration that boosts its water security and energy transition capabilities.

Memphasys has initiated clinical utility testing of its Felix™ System in Brazil through a partnership with Laboratorio Androscience, aiming to establish a foothold in the rapidly growing Latin American IVF sector.

Aurizon Holdings reported a 3% revenue increase in its half-year FY2025 results, driven by higher coal volumes, but underlying NPAT fell 14% due to rising costs and customer mix effects. The company’s strong free cash flow supports an expanded $300 million buy-back program.

Aurizon Holdings posted a 3% revenue increase to $2.02 billion for 1HFY2025 but saw EBITDA dip 4% to $814 million, reflecting operational headwinds across key segments. The company declared a 9.2 cents per share interim dividend, signaling cautious optimism despite margin pressures.